Trial Profile
A Prospective, Randomized, Single-Blind, Active Control Trial to Compare Safety and Effectiveness Of Liposomal Bupivacaine (Exparel) to Standard Bupivacaine HCl (Marcaine) for Pain Management in Patients Undergoing Video-Assisted Thoracoscopic Lobectomy
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Jan 2023
Price :
$35
*
At a glance
- Drugs Bupivacaine (Primary) ; Bupivacaine/epinephrine (Primary)
- Indications Intraoperative pain
- Focus Therapeutic Use
- Acronyms BEMP
- 16 Dec 2022 Status changed from active, no longer recruiting to completed.
- 03 Nov 2021 Planned End Date changed from 5 Dec 2023 to 3 Sep 2022.
- 03 Nov 2021 Planned primary completion date changed from 5 Jul 2023 to 3 Sep 2022.